DiPaola, R S <br/><br/>
Targeting apoptosis in prostate cancer.  [electronic resource] 

 -  Hematology/oncology clinics of North America  Jun 2001 
 - 509-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0889-8588 
<br/><br/><label>Standard No.: </label>10.1016/s0889-8588(05)70229-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Caspases--physiology<br/>Cysteine Endopeptidases<br/>Cysteine Proteinase Inhibitors--pharmacology<br/>Disease Progression<br/>Drug Design<br/>Drug Resistance, Neoplasm--genetics<br/>Enzyme Inhibitors--pharmacology<br/>Fas Ligand Protein<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Genes, bcl-2<br/>Genes, p53<br/>Humans<br/>Interferons--therapeutic use<br/>Male<br/>Membrane Glycoproteins--physiology<br/>Mice<br/>Mice, Knockout<br/>Mitochondria--physiology<br/>Multienzyme Complexes--antagonists & inhibitors<br/>NF-kappa B--physiology<br/>Neoplasm Proteins--genetics<br/>Oligonucleotides, Antisense--therapeutic use<br/>Phosphatidylinositol 3-Kinases--physiology<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Pilot Projects<br/>Prostatic Neoplasms--drug therapy<br/>Proteasome Endopeptidase Complex<br/>Protein Serine-Threonine Kinases<br/>Proto-Oncogene Proteins--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-akt<br/>Proto-Oncogene Proteins c-bcl-2--physiology<br/>Retinoids--therapeutic use<br/>Tumor Suppressor Protein p53--physiology